{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:47:28Z","timestamp":1790621248777,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":2190,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.7861\/clinmedicine.18-2-s1","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T11:55:13Z","timestamp":1524743713000},"page":"s1-s8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S","title":["Valproate: life-saving, life-changing"],"prefix":"10.1016","volume":"18","author":[{"given":"Rhys H","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.18-2-s1_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.7861\/clinmedicine.18-2-s1_bib2","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmedicine.18-2-s1_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.7861\/clinmedicine.18-2-s1_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","article-title":"Management issues for women with epilepsy\u2013Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.7861\/clinmedicine.18-2-s1_bib7","first-page":"CD004848","article-title":"Common antiepileptic drugs in pregnancy in women with epilepsy","author":"Adab","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.7861\/clinmedicine.18-2-s1_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","article-title":"Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"},{"key":"10.7861\/clinmedicine.18-2-s1_bib9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.7861\/clinmedicine.18-2-s1_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/epi.13007","article-title":"Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy","volume":"56","author":"Wood","year":"2015","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib11","doi-asserted-by":"crossref","first-page":"36250","DOI":"10.1038\/srep36250","article-title":"The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy","volume":"6","author":"Choi","year":"2016","journal-title":"Sci Rep"},{"key":"10.7861\/clinmedicine.18-2-s1_bib12","year":"2015","journal-title":"Medicines related to valproate: risk of abnormal pregnancy outcomes"},{"key":"10.7861\/clinmedicine.18-2-s1_bib13","series-title":"Valproate and risk of abnormal pregnancy outcomes: new communication materials","year":"2016"},{"key":"10.7861\/clinmedicine.18-2-s1_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.7861\/clinmedicine.18-2-s1_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00415-012-6662-8","article-title":"Generalized tonic-clonic seizures and antiepileptic drugs during pregnancy\u2013a matter of importance for the baby?","volume":"260","author":"Rauchenzauner","year":"2013","journal-title":"J Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib18","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy","volume":"50","author":"Veiby","year":"2009","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib19","doi-asserted-by":"crossref","first-page":"52339","DOI":"10.1371\/journal.pone.0052339","article-title":"Antiepileptic drugs during pregnancy in primary care: a UK population based study","volume":"7","author":"Man","year":"2012","journal-title":"PLoS One"},{"key":"10.7861\/clinmedicine.18-2-s1_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrneurol.2014.62","article-title":"The hidden genetics of epilepsy-a \u00adclinically important new paradigm","volume":"10","author":"Thomas","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1474-4422(16)30359-3","article-title":"Ultra-rare genetic variation in common epilepsies: a case-control sequencing study","volume":"16","author":"Epi4K consortium, Epilepsy Phenome\/Genome Project","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib22","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","article-title":"Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis","volume":"386","author":"Viale","year":"2015","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.18-2-s1_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/epi.13029","article-title":"Valproate still has a place in women with epilepsy","volume":"56","author":"Perucca","year":"2015","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first anti\u00adepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.7861\/clinmedicine.18-2-s1_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/epi.12942","article-title":"Epilepsy and deprivation, a data linkage study","volume":"56","author":"Pickrell","year":"2015","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.18-2-s1_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and epilepsy-related mortality in pregnancy","volume":"55","author":"Edey","year":"2014","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.seizure.2016.10.002","article-title":"Sudden death in epilepsy: insights from the last 25 years","volume":"44","author":"Jones","year":"2017","journal-title":"Seizure"},{"key":"10.7861\/clinmedicine.18-2-s1_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1753495X14553257","article-title":"Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review","volume":"7","author":"Kapoor","year":"2014","journal-title":"Obstet Med"},{"key":"10.7861\/clinmedicine.18-2-s1_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of \u00advalproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.7861\/clinmedicine.18-2-s1_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-0348-8759-5_1","article-title":"The discovery of valproate. In: L\u00f6scher W, ed","author":"L\u00f6scher","year":"1999","journal-title":"Valproate."},{"key":"10.7861\/clinmedicine.18-2-s1_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp Neurobiol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fncel.2014.00023","article-title":"Late onset deficits in synaptic plasticity in the valproic acid rat model of autism","volume":"8","author":"Martin","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.7861\/clinmedicine.18-2-s1_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yebeh.2014.03.026","article-title":"Executive functions and \u00adpsychiatric symptoms in drug-refractory juvenile myoclonic \u00adepilepsy","volume":"35","author":"Walsh","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.7861\/clinmedicine.18-2-s1_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yebeh.2014.04.027","article-title":"A comprehensive neuro\u00adpsychological description of cognition in drug-refractory juvenile \u00admyoclonic epilepsy","volume":"36","author":"Thomas","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.7861\/clinmedicine.18-2-s1_bib36","first-page":"20","article-title":"Are antiepileptic drugs harmful when given during pregnancy?","volume":"9","author":"Janz","year":"1964","journal-title":"Ger Med Mon"},{"key":"10.7861\/clinmedicine.18-2-s1_bib37","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/j.1528-1167.2008.01696.x","article-title":"Valproate teratogenicity and epilepsy syndrome","volume":"49","author":"Bromfield","year":"2008","journal-title":"Epilepsia"},{"key":"10.7861\/clinmedicine.18-2-s1_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/jrsm.2011.100412","article-title":"Epilepsy is different","volume":"104","author":"Thomas","year":"2011","journal-title":"J R Soc Med"},{"key":"10.7861\/clinmedicine.18-2-s1_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/mp.2016.113","article-title":"Clinical genomics expands the morbid genome of intellectual disability and offers a high \u00addiagnostic yield","volume":"22","author":"Anazi","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.7861\/clinmedicine.18-2-s1_bib40","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(14)61705-0","article-title":"Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data","volume":"385","author":"Wright","year":"2015","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.18-2-s1_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tox.2011.03.017","article-title":"Gene set assembly for quantitative prediction of developmental toxicity in the embryonic stem cell test","volume":"284","author":"Pennings","year":"2011","journal-title":"Toxicology"},{"key":"10.7861\/clinmedicine.18-2-s1_bib42","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00415-016-8269-y","article-title":"The consequences of valproate \u00adexposure in utero","volume":"263","author":"Thomas","year":"2016","journal-title":"J Neurol"},{"key":"10.7861\/clinmedicine.18-2-s1_bib43","unstructured":"43 European Medicines Agency,. PRAC recommends new measures to avoid valproate exposure in pregnancy EMA\/67672\/2018 www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2018\/02\/WC500243555.pdf, [Accessed 2 March 2018]"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.18-2-s1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:31:48Z","timestamp":1761460308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1470211824000782"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.18-2-s1","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate: life-saving, life-changing","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.18-2-s1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2018. All rights reserved.","name":"copyright","label":"Copyright"}]}}